Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 19/20 | 0.63 |
| ▸ | ALOX5 | P09917 | 9/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.60 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9581549 | 0.92 | PTGES2 (0.70) | ALOX5APALOX5CYP3A4CYP2C9PTGES2 | |
| SCHEMBL30181651 | 0.88 | PTGES2 (0.67) | ALOX5APALOX5CYP3A4CYP2C9PTGES2 | |
| SCHEMBL169604 | 0.88 | PTGES2 (0.67) | ALOX5APALOX5CYP3A4CYP2C9PTGES2 | |
| SCHEMBL1192956 | 0.88 | ALOX5AP (0.81) | ALOX5APALOX5CYP3A4CYP2C9PTGES2 | |
| SCHEMBL1193638 | 0.87 | ALOX5AP (0.63) | ALOX5APALOX5CYP3A4CYP2C9PTGES2 | |
| SCHEMBL25968196 | 0.85 | PTGES2 (0.67) | ALOX5APALOX5CYP3A4CYP2C9PTGES2 | |
| SCHEMBL9047849 | 0.85 | PTGES2 (0.62) | ALOX5APALOX5CYP3A4CYP2C9PTGES2 | |
| SCHEMBL167199 | 0.85 | PTGES2 (0.66) | ALOX5APALOX5CYP3A4CYP2C9PTGES2 | |
| SCHEMBL9447575 | 0.83 | ALOX5AP (0.79) | ALOX5APALOX5CYP3A4CYP2C9CYP2D6 | |
| SCHEMBL9304834 | 0.83 | ALOX5AP (0.83) | ALOX5APALOX5CYP3A4CYP2C9CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5420282-A | Inhibitors of leukotriene biosynthesis | ABBOTT LABORATORIES (US) | 1995-05-30 | — | — | US | disclosed |